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© 200? The Japan Society of Histochemistry and Cy- We and others have previously shown that reactive microglia express the major histo-
compatibility complex (MHC) class I and class II antigens in the hippocampus of patients
suffering from epilepsy. Although the MHC glycoproteins serve as restriction elements for
T lymphocytes, there is little information available regarding T lymphocytes in hippocampal
sclerosis. In the present study, we investigated T lymphocyte infiltration in human hippo-
campi in four cases of epilepsy with hippocampal sclerosis, as well as in four control cases
without neurological disease. No CD8- or CD4-positive T lymphocytes were seen in hippo-
campi from the control cases. In contrast, CD8- and CD4-positive T lymphocytes had infil-
trated into the hippocampi of patients with hippocampal sclerosis. In addition, expression of
intercellular adhesion molecule-1 was diffusely upregulated in the hippocampi with hippo-
campal sclerosis. These results indicate that T lymphocyte infiltration is involved in the
pathology of hippocampal sclerosis.
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I. Introduction
Hippocampal sclerosis (HS), the most common patho-
logical finding in temporal lobe epilepsy, is characterized
by prominent neuronal loss, mossy fiber sprouting, and
astroglial proliferation [22]. In addition, reactive microglia
in the hippocampi of epilepsy patients express major histo-
compatibility complex (MHC) class I and class II antigens
[6]. The MHC I and II antigens are also expressed in rat
models of epilepsy, such as those with kainic acid (KA)-
induced seizures [1, 3, 8, 14]. The expression of MHC
antigens on microglia has been reported in several neuro-
degenerative disorders, including Alzheimer’s disease (AD)
and amyotrophic lateral sclerosis [11, 15, 20, 23]. These
conditions are characterized by microglial activation in the
affected brain regions. Reactive microglia produce several
inflammatory factors associated with immune responses
[4, 16].
The MHC glycoproteins serve as restriction elements
for T lymphocytes. The MHC I and II antigens play a role in
antigen  presentation  for  T  cytotoxic/suppressor  lympho-
cytes (CD8) and T helper (Th)/inducer (CD4) lymphocytes,
respectively [12]. Although these lymphocytes are not
observed in the parenchyma of normal brains, they do in-
filtrate the parenchyma in AD [10] and chronic encephalitis
(e.g. Rasmussen encephalitis) [13]. However, it remains
uncertain whether these T lymphocytes are found in the
hippocampi of patients with temporal lobe epilepsy. In
animal models of epilepsy, it has been reported that leuko-
cytes, including T lymphocytes, infiltrate the hippocampus
[3, 25]. In the hippocampi of epilepsy model rats, inter-
cellular adhesion molecule-1 (ICAM-1) is expressed in the
blood vessels, followed by leukocyte infiltration [3]. Be-
cause leukocytes express lymphocyte function-associated
antigen-1 (LFA-1), a ligand for ICAM-1, we proposed thatNakahara et al. 158
the expression of ICAM-1 may be a trigger for the infil-
tration of T lymphocytes into the hippocampus when epi-
lepsy occurs [3]. In the present study, we investigated
whether the same phenomenon occurs in the hippocampi
of patients with HS. We also evaluated the presence of T
lymphocytes and ICAM-1 in the hippocampi of epileptic
patients with and without HS, as well as in neurologically
normal controls.
II. Materials and Methods
Tissue preparation
The present study was approved by the Ethics Commit-
tee at Shiga University of Medical Science. Four cases of HS
were compared with one surgically excised hippocampus
and three non-HS hippocampi obtained at autopsy. All HS
patients satisfied commonly accepted criteria for surgery,
with intractable seizures emanating from temporal lobe foci.
All autopsy cases died suddenly without any history of
neurological disease. The clinicopathological features of
all cases are given in Table 1. Brain tissues were sliced,
fixed by immersion in formalin (4% formaldehyde, phos-
phate buffered, pH 7.4) for 2 days, and then placed in 10 mM
phosphate-buffered saline (PBS) containing 15% sucrose
and 0.1% sodium azide at 4°C for cryoprotection. Tissues
were cut into 40-µm sections on a freezing microtome.
Sections were collected in 10 mM PBS containing 0.1%
sodium azide and stored at 4°C until use.
Immunohistochemistry
For immunohistochemistry, sections were incubated in
0.5% hydrogen peroxide in 0.1 M PBS (pH 7.4) containing
0.3% Triton-X100 (PBST) for 30 min at room temperature
to eliminate endogenous peroxidase. After washing with
PBST, sections were incubated for 30 min with PBST
containing 2% bovine serum albumin to block non-specific
protein binding. Sections were then incubated for 1–3 days
at 4°C with a mouse monoclonal antibody directed against
CD4 (1:100 dilution; Nichirei, Tokyo, Japan) or CD8 (1:100
dilution; Nichirei) or a rabbit polyclonal antibody against
ICAM-1 (1:500 dilution; Beckman Coulter, Marseille,
France). After washing with PBST, sections were incubated
at room temperature for another 1 hr with biotinylated anti-
mouse or anti-rabbit IgG (1:1000 dilution; Vector Laborato-
ries, Burlingame, CA, USA), followed by 1 hr incubation at
room temperature with avidin-biotinylated peroxidase com-
plex (1:4000 dilution; Vector Laboratories). Sections were
then incubated with 0.02% 3,3'-diaminobenzidine (DAB)
and 0.3% nickel ammonium sulfate in 50 mM Tris-HCl
buffer (pH 7.6) to precipitate a purple chromogen.
For double immunostaining, some sections were incu-
bated with 0.5% hydrogen peroxidase in 0.1 M PBST for
30 min at room temperature after the first cycle of staining
for CD4 or CD8. After washing with PBST, the sections
were incubated with mouse monoclonal antibody against
CD31 (1:500 dilution; Dako, Glostrup, Denmark) or rabbit
polyclonal antibody against Iba1 (1:1000 dilution; Wako
Pure Chemicals, Osaka, Japan). After washing with PBST,
sections were incubated with peroxidase-labeled anti-mouse
or anti-rabbit IgG (1:10 dilution; Histofine; Nichirei) for
1 hr at room temperature. Peroxidase labeling was detected
by incubating the sections with 0.02% DAB and 0.0045%
hydrogen peroxide in 50 mM Tris HCl buffer (pH 7.6) to
precipitate a brown chromogen.
The specificity of ICAM-1 staining was examined by
an immunoabsorption test. The sections were stained using
the ICAM-1 antibody pre-incubated for 2 hr at room tem-
perature with 5 µg/ml of ICAM-1 protein (Abcam Japan,
Tokyo, Japan).
Cell counting
The number of CD4- or CD8-immunopositive cells
was determined in three 20-µm sections. The entire area of
each section was divided into 4400×3300  µm grids and
each grid was then serially entered into a computer using a
microscopic image analysis system (Biozero; Keyence,
Osaka, Japan). The entire area of each section was then
reconstructed by the computer and the total area of the
hippocampal formation was determined using ImageJ 1.43
medical imaging software (National Institutes of Health,
Maryland, USA). The number of cells was determined
visually and cell counts were corrected for cell size [9]. The
actual calculated number of cells (N) was obtained using
the following formula:
Table 1. Clinicopathological features of patients
Case no. Age (years) Sex Postmortem delay Diagnosis
Hippocampal sclerosis
1 27 M Surgical specimen Hippocampal sclerosis
2 29 M Surgical specimen Hippocampal sclerosis
3 45 M Surgical specimen Hippocampal sclerosis
4 39 F Surgical specimen Hippocampal sclerosis
Control cases
5 31 M Surgical specimen Head trauma
6 21 M 10 hr Acute morphine overdose
7 44 M 4 hr Suicide
8 24 F 8 hr Heart traumaNeuroinflammation in the Epilepsy 159
N = n × (T/(T + h))
where n is the number of cell bodies, T is the thickness of the
section, and h is the average diameter of the counted cell.
III. Results
In control cases, no CD4- or CD8-positive lymphocytes
(Fig. 1A, B) were found in the hippocampal parenchyma.
However, in all epileptic patients with HS, CD4-positive
(Fig. 1C, D) and CD8-positive (Fig. 1E, F) lymphocytes
were observed to have infiltrated into the hippocampus
(Table 2). Double-staining for T lymphocytes and CD31
showed CD4- and CD8-positive T lymphocytes within
the parenchyma adjacent to blood vessels (Fig. 1C–F).
Although the number of positive lymphocytes varied
from case to case, in all cases the number of CD8-positive
cells was significantly greater than the number of CD4-
positive cells (p<0.01; Table 2). Figure 2 shows double
immunostaining for CD4 and Iba1, a marker for microglia/
macrophages. It can be seen that the CD4-positive cells
constitute a separate subpopulation of cells to the Iba1-
positive microglia/macrophages (Fig. 2).
Weak ICAM-1 expression was observed in the blood
vessels of hippocampi from control cases (Fig. 3A). In
hippocampi from patients with HS (Fig. 3B), diffuse ICAM-
1 staining appeared in the parenchyma with the exception
of the dentate gyrus (Fig. 3B). At higher magnification, it
was evident that ICAM-1 staining was increased in vascular
walls and diffuse staining was observed from the vascular
Fig. 1. Immunohistochemical staining for CD4 (A, C) and CD8 (B, D) in hippocampal sections from control patients (A, B) and patients with
hippocampal sclerosis (C, D). Vessels were counter-stained with CD31 (brown). (A, B) No CD-4- or CD8-positive lymphocytes are seen in
control sections. (C–F) Many CD-4-positive (C, D; arrows) and CD8-positive (E, F; arrows) lymphocytes are seen in the parenchyma in
hippocampal sclerosis. Bars=100 µm (A, B, C, E) and 50 µm (D, F).
Table 2. Number of T lymphocytes in hippocampal sections
Case no.
No. CD4 
lymphocytes 
(/mm2)
No. CD8 
lymphocytes 
(/mm2)
Hippocampal sclerosis
1 119 174
2 6 278
38 1 6
42 1 6 8
Control cases
50 2
60 0
71 7
84 1 2Nakahara et al. 160
walls to the parenchyma (Fig. 3C). The preincubation of
the ICAM-1 antibody with 5 µg/ml of ICAM-1 protein
abolished the staining (Fig. 3D).
IV. Discussion
The present study has demonstrated that CD4- and
CD8-positive T lymphocytes infiltrate into the parenchyma
of sclerotic hippocampi. Previous studies have reported
that MHC class I and class II antigens are expressed in the
hippocampi of epileptic patients [6], as well as in rat models
of epilepsy, including those with KA-induced seizures [1,
3, 8, 14]. These observations, together with the results of
the present study, suggest that immunoinflammation occurs
in the hippocampus in HS. Interestingly, in all cases exam-
ined in the present study, the number of CD8-positive cells
was significantly greater than the number of CD4-positive
cells. These results are consistent with recent observations
in an animal model of epilepsy [21].
A previous study has reported that, in addition to
microglial activation, perivascular cells are observed in
the hippocampus in HS [6]. The results of the present study
indicate that some of these perivascular cells are T lym-
phocytes. Quantitatively, the number of T lymphocytes
varied among cases of HS. This suggests that there is some
unknown factor/s influencing T cell infiltration.
A previous study has reported no T cells in the paren-
chyma of HS cases [19]. The reason for the apparent dis-
crepancy between that study and the present study remains
unknown. However, there are several possibilities. First,
the previous study investigated 6-µm formalin-fixed and
paraffin-embedded sections [19], whereas in the present
study we fixed hippocampal tissues for 2 days in 4%
paraformaldehyde with 0.1 M phosphate buffer (pH 7.4)
before cutting 20-µm sections from the tissue blocks. The
weak fixation process we used may have preserved anti-
genicity compared with formalin fixation and paraffin em-
bedding. In addition, the T cell makers used in the two
studies differ. The previous report used CD3 [19], whereas
in the present study we used CD4 and CD8. Thus, technical
differences between the two studies may explain the
discrepancy.
In patients with Rasmussen’s encephalitis, a refractory
seizure disorder, T (CD4, CD8) and B lymphocytes are
present in the brain [17]. In these patients, cytotoxic T cells
kill neurons [7]. In the present study, we found that the
number of cytotoxic T cells (CD8) was greater than the
number of Th cells (CD4) in samples from patients with HS.
This observation is consistent with a recent study using KA
[21]. Together, the results suggest that T cell infiltration
may be involved in neuronal loss in HS. However, in order
Fig. 2. Double immunostaining for CD4 and Iba1 showing that
the CD4-positive cells (purple; arrows) are separate to the Iba1-
positive cells (brown). Bar=50 µm.
Fig. 3. Immunohistochemical staining for intercellular adhesion molecule-1 (ICAM-1) in the hippocampus. (A) Control; (B–D) hippocampal
sclerosis (HS). In the control sections (A), vessels are weakly stained for ICAM-1. In contrast, in sections from patients with HS (B, C), ICAM-
1 staining is diffusely increased in the fourth sector of the cornus ammonium (CA4), but not in the dentate gyrus (DG). (D) The preincubation of
the ICAM-1 antibody with 5 µg/ml of ICAM-1 protein abolish the staining. Bars=200 µm (A, B, D) and 50 µm (C).Neuroinflammation in the Epilepsy 161
to clarify this issue, further studies are needed.
As reported previously [2], we found weak ICAM-1
expression in blood vessels in samples from control cases.
Interestingly, ICAM-1 expression was increased in the pa-
renchyma of hippocampal sections from patients with HS.
It has been reported that ICAM-1 expression is increased by
inflammatory responses [25]. Therefore, the results of the
present study may suggest that immunoinflammation occurs
in the sclerotic hippocampus.
In AD cases, increased ICAM-1 expression has been
reported in the parenchyma [2], as well as T cell infiltration
[10]. Similar findings have been made in the cortex of AD
cases [2]. Because lymphocytes express a ligand for ICAM-
1 (i.e. LFA-1), ICAM-1 in the parenchyma may induce T
cell infiltration in both HS and AD. In the mouse brain,
ICAM-1 expression in vessels increases following transient
cerebral ischemia [18] and, in addition to being expressed
in the blood vessels, ICAM-1 is found in the astrocytes 24
hr after treatment [18]. However, we did not find any ICAM-
1-positive astrocytes in samples from patients with HS,
nor were ICAM-1-positive astrocytes found in rat brains
following KA treatment [3]. The differences between these
studies suggest that ICAM-1 has different pathological roles
in cerebral ischemia compared with HS.
Quantitative values for CD4- and CD8-positive cells
varied among cases. This suggests that there may be some
unknown factor/s influencing T cell infiltration. Bauer et al.
have reported that seizure activity itself may trigger the
release of chemical factors, such as cytokines, into the
surrounding tissue in addition to epinephrine secretion [5].
Uchikado et al. reported that systemic inflammation affects
the expression of several cytokines, including ICAM-1, in
the human brain [25]. T cell infiltration in HS may be influ-
enced by these factors.
We have reported previously that activated microglia
expressing MHC class II antigens were found in HS with
temporal lobe epilepsy [6]. Animal studies have shown that
such activation can occur in response to a number of differ-
ent forms of injury, all of which may act by inducing neu-
ronal cell death or degeneration of neuronal processes. In
epileptic rat models, microglial activation is closely related
to neuronal death processes [24]. The activated microglia
found in HS suggest ongoing degenerative processes. The T
cell infiltration demonstrated in the present study supports
this possibility.
As noted above, Bauer et al. have reported that seizure
activity itself may trigger the release of chemical factors in
addition to epinephrine, thereby inducing inflammation [5].
Thus, it may be that several cytokines and epinephrine are
secreted in HS, although this possibility requires further
investigation.
In conclusion, the present study has shown increased
ICAM-1 expression and infiltration of CD8- and CD4-
positive T lymphocytes in the hippocampus of patients with
HS.
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